• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.变构抑制剂、晶体学和比较分析揭示人类疱疹病毒蛋白酶的协同运动网络。
J Am Chem Soc. 2017 Aug 30;139(34):11650-11653. doi: 10.1021/jacs.7b04030. Epub 2017 Aug 17.
2
Protease dimer formation disrupted.蛋白酶二聚体形成被破坏。
Nat Chem Biol. 2009 Sep;5(9):607-8. doi: 10.1038/nchembio0909-607.
3
Inhibition of a viral enzyme by a small-molecule dimer disruptor.小分子二聚体干扰剂对病毒酶的抑制作用。
Nat Chem Biol. 2009 Sep;5(9):640-6. doi: 10.1038/nchembio.192. Epub 2009 Jul 26.
4
Herpesvirus protease inhibition by dimer disruption.通过破坏二聚体抑制疱疹病毒蛋白酶
J Virol. 2004 Jun;78(12):6657-65. doi: 10.1128/JVI.78.12.6657-6665.2004.
5
Broad-spectrum allosteric inhibition of herpesvirus proteases.广谱别构抑制剂抑制疱疹病毒蛋白酶。
Biochemistry. 2014 Jul 22;53(28):4648-60. doi: 10.1021/bi5003234. Epub 2014 Jul 11.
6
Enzyme inhibition by allosteric capture of an inactive conformation.别构捕获无活性构象抑制酶活性。
J Mol Biol. 2011 Sep 2;411(5):999-1016. doi: 10.1016/j.jmb.2011.06.032. Epub 2011 Jun 22.
7
Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.病毒二聚体蛋白酶的基于片段的蛋白质-蛋白质相互作用拮抗剂
ChemMedChem. 2016 Apr 19;11(8):862-9. doi: 10.1002/cmdc.201500526. Epub 2016 Jan 28.
8
Substrate modulation of enzyme activity in the herpesvirus protease family.疱疹病毒蛋白酶家族中酶活性的底物调节
J Mol Biol. 2007 Nov 2;373(4):913-23. doi: 10.1016/j.jmb.2007.07.073. Epub 2007 Aug 16.
9
A screening strategy for trapping the inactive conformer of a dimeric enzyme with a small molecule inhibitor.一种利用小分子抑制剂捕获二聚体酶非活性构象的筛选策略。
Methods Mol Biol. 2012;928:119-31. doi: 10.1007/978-1-62703-008-3_9.
10
Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements.卡波西肉瘤相关疱疹病毒蛋白酶结构的功能后果:保守结构元件对活性和二聚化的调控
Biochemistry. 2000 Oct 24;39(42):12796-803. doi: 10.1021/bi001019h.

引用本文的文献

1
Discovery of acylphloroglucinol-based meroterpenoid enantiomers as KSHV inhibitors from .从……中发现基于间苯三酚酰基的萜类半合成对映体作为卡波西肉瘤相关疱疹病毒抑制剂
RSC Adv. 2018 Jul 2;8(43):24101-24109. doi: 10.1039/c8ra04073g.
2
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine.靶向非催化半胱氨酸抑制动态病毒蛋白酶。
Cell Chem Biol. 2022 May 19;29(5):785-798.e19. doi: 10.1016/j.chembiol.2022.03.007. Epub 2022 Mar 31.
3
Which Properties Allow Ligands to Open and Bind to the Transient Binding Pocket of Human Aldose Reductase?哪些性质使配体能够打开并结合到人醛糖还原酶的瞬时结合口袋?
Biomolecules. 2021 Dec 6;11(12):1837. doi: 10.3390/biom11121837.
4
High throughput and quantitative enzymology in the genomic era.高通量和定量酶学在基因组时代。
Curr Opin Struct Biol. 2021 Dec;71:259-273. doi: 10.1016/j.sbi.2021.07.010. Epub 2021 Sep 27.
5
Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.卡波西肉瘤疱疹病毒相关疾病治疗方法的最新进展。
Viruses. 2021 Sep 9;13(9):1797. doi: 10.3390/v13091797.
6
Advances in methods for atomic resolution macromolecular structure determination.原子分辨率大分子结构测定方法的进展。
F1000Res. 2020 Jul 2;9. doi: 10.12688/f1000research.25097.1. eCollection 2020.
7
Structure-Based Analysis of Cryptic-Site Opening.基于结构的隐匿位点开启分析。
Structure. 2020 Feb 4;28(2):223-235.e2. doi: 10.1016/j.str.2019.11.007. Epub 2019 Dec 3.
8
Predicting allostery and microbial drug resistance with molecular simulations.利用分子模拟预测别构和微生物药物耐药性。
Curr Opin Struct Biol. 2018 Oct;52:80-86. doi: 10.1016/j.sbi.2018.09.001. Epub 2018 Sep 19.
9
Cryptic binding sites on proteins: definition, detection, and druggability.蛋白质上的隐匿结合位点:定义、检测和可成药性。
Curr Opin Chem Biol. 2018 Jun;44:1-8. doi: 10.1016/j.cbpa.2018.05.003. Epub 2018 May 23.

本文引用的文献

1
CryptoSite: Expanding the Druggable Proteome by Characterization and Prediction of Cryptic Binding Sites.CryptoSite:通过隐秘结合位点的表征与预测扩展可成药蛋白质组
J Mol Biol. 2016 Feb 22;428(4):709-719. doi: 10.1016/j.jmb.2016.01.029. Epub 2016 Feb 5.
2
Dimerization-Induced Allosteric Changes of the Oxyanion-Hole Loop Activate the Pseudorabies Virus Assemblin pUL26N, a Herpesvirus Serine Protease.氧阴离子洞环的二聚化诱导变构变化激活伪狂犬病病毒装配蛋白pUL26N,一种疱疹病毒丝氨酸蛋白酶。
PLoS Pathog. 2015 Jul 10;11(7):e1005045. doi: 10.1371/journal.ppat.1005045. eCollection 2015 Jul.
3
Current and potential treatments for ubiquitous but neglected herpesvirus infections.常见但被忽视的疱疹病毒感染的现有及潜在治疗方法。
Chem Rev. 2014 Nov 26;114(22):11382-412. doi: 10.1021/cr500255e. Epub 2014 Oct 2.
4
Broad-spectrum allosteric inhibition of herpesvirus proteases.广谱别构抑制剂抑制疱疹病毒蛋白酶。
Biochemistry. 2014 Jul 22;53(28):4648-60. doi: 10.1021/bi5003234. Epub 2014 Jul 11.
5
Accessing protein conformational ensembles using room-temperature X-ray crystallography.利用室温 X 射线晶体学获取蛋白质构象组。
Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16247-52. doi: 10.1073/pnas.1111325108. Epub 2011 Sep 14.
6
Enzyme inhibition by allosteric capture of an inactive conformation.别构捕获无活性构象抑制酶活性。
J Mol Biol. 2011 Sep 2;411(5):999-1016. doi: 10.1016/j.jmb.2011.06.032. Epub 2011 Jun 22.
7
Inhibition of a viral enzyme by a small-molecule dimer disruptor.小分子二聚体干扰剂对病毒酶的抑制作用。
Nat Chem Biol. 2009 Sep;5(9):640-6. doi: 10.1038/nchembio.192. Epub 2009 Jul 26.
8
Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA.单纯疱疹病毒DNA包装所需病毒基因产物的鉴定与特性分析。
J Virol. 1983 Mar;45(3):1056-64. doi: 10.1128/JVI.45.3.1056-1064.1983.
9
The behavior and significance of slow-binding enzyme inhibitors.慢结合酶抑制剂的行为及意义
Adv Enzymol Relat Areas Mol Biol. 1988;61:201-301. doi: 10.1002/9780470123072.ch5.

变构抑制剂、晶体学和比较分析揭示人类疱疹病毒蛋白酶的协同运动网络。

Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.

机构信息

Department of Pharmaceutical Chemistry, University of California , San Francisco, California 94158, United States.

Department of Bioengineering and Therapeutic Sciences, University of California , San Francisco, California 94158, United States.

出版信息

J Am Chem Soc. 2017 Aug 30;139(34):11650-11653. doi: 10.1021/jacs.7b04030. Epub 2017 Aug 17.

DOI:10.1021/jacs.7b04030
PMID:28759216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6089631/
Abstract

Targeting of cryptic binding sites represents an attractive but underexplored approach to modulating protein function with small molecules. Using the dimeric protease (Pr) from Kaposi's sarcoma-associated herpesvirus (KSHV) as a model system, we sought to dissect a putative allosteric network linking a cryptic site at the dimerization interface to enzyme function. Five cryogenic X-ray structures were solved of the monomeric protease with allosteric inhibitors bound to the dimer interface site. Distinct coordinated movements captured by the allosteric inhibitors were also revealed as alternative states in room-temperature X-ray data and comparative analyses of other dimeric herpesvirus proteases. A two-step mechanism was elucidated through detailed kinetic analyses and suggests an enzyme isomerization model of inhibition. Finally, a representative allosteric inhibitor from this class was shown to be efficacious in a cellular model of viral infectivity. These studies reveal a coordinated dynamic network of atomic communication linking cryptic binding site occupancy and allosteric inactivation of KHSV Pr that can be exploited to target other members of this clinically relevant family of enzymes.

摘要

靶向隐匿结合位点是一种有吸引力但尚未充分探索的方法,可以用小分子来调节蛋白质功能。我们以卡波济肉瘤相关疱疹病毒(KSHV)的二聚体蛋白酶(Pr)为模型系统,试图剖析连接二聚体界面隐匿位点与酶功能的假定别构网络。我们解决了五个与别构抑制剂结合的单体蛋白酶的低温 X 射线结构。别构抑制剂所捕捉到的独特协调运动也在室温 X 射线数据和其他二聚体疱疹病毒蛋白酶的比较分析中揭示为替代状态。通过详细的动力学分析阐明了两步机制,并提出了抑制的酶变构模型。最后,该类别的代表性别构抑制剂在病毒感染的细胞模型中显示出疗效。这些研究揭示了一个协调的原子通讯动态网络,将隐匿结合位点占据和 KHSV Pr 的别构失活联系起来,可以利用这个网络来靶向这个具有临床相关性的酶家族的其他成员。